Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-Prostatectomy RT, Hormonal Therapy and Docetaxel for High Risk Prostate Cancer
NCT00669162Phase 2Completed
- Sponsor
- University of Kansas Medical Center
- Start
- Aug 2012
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in prostate cancer (PCa), sponsored by University of Kansas Medical Center. Started Aug 2012; status: completed.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00669162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00669162.